Castration-resistant Prostate Cancer Clinical Trials
0 recruiting
Showing 1–15 of 15 trials
Recruiting
Phase 1Phase 2
A Study of Terbium 161 (161Tb)-RAD402 in Participants With CRPC
Castration-resistant Prostate Cancer
Radiopharm Theranostics, Ltd73 enrolled1 locationNCT07259213
Recruiting
Phase 1
Study of DCC-2812 in Participants With Advanced Genitourinary Cancers
Urothelial CarcinomaRenal Cell CarcinomaCastration-resistant Prostate Cancer
Deciphera Pharmaceuticals, LLC60 enrolled3 locationsNCT06966024
Recruiting
Phase 2
Study of Apalutamide With Carotuximab in Metastatic, Castration-Resistant Prostate Cancer
Castration-resistant Prostate Cancer
Edwin Posadas, MD100 enrolled3 locationsNCT05534646
Recruiting
Phase 1
GZ17-6.02 in Advanced CRPC After Progression on Anti-Androgen Therapy
Castration-resistant Prostate Cancer
Virginia Commonwealth University30 enrolled1 locationNCT06636123
Recruiting
Phase 2
Study of Cabozantinib and Nivolumab in Metastatic Castration Resistant Prostate Cancer
Metastatic CancerCastration-resistant Prostate Cancer
Rana McKay, MD47 enrolled4 locationsNCT05502315
Recruiting
Phase 2
Stereotactic Body Radiation Therapy Plus Immediate or Delayed Androgen Receptor Pathway Inhibitor and Androgen Deprivation Therapy or Salvage Radiation Therapy for the Treatment of Prostate Cancer, DIVINE Trial
Biochemically Recurrent Prostate CarcinomaRecurrent Castration-Sensitive Prostate CarcinomaRecurrent Prostate Cancer+1 more
Mayo Clinic532 enrolled3 locationsNCT06378866
Recruiting
ARCTIC: Liquid Biomarkers in the Prospective Androgen Receptor Signaling Inhibitors (ARSI) Resistance Clinical Trials
Prostate CancerProstate Cancer MetastaticProstate Adenocarcinoma+1 more
Duke University120 enrolled3 locationsNCT06141993
Recruiting
Phase 2
Bipolar Androgen Therapy + Carboplatin in mCRPC
Homologous Recombination DeficiencyCastration-resistant Prostate Cancer
St Vincent's Hospital, Sydney30 enrolled1 locationNCT03522064
Recruiting
Phase 1
Clinical Study of Safety and Efficacy of Universal PSMA CAR- T in Refractory CRPC
Metastatic Prostate CancerMetastatic Castration-resistant Prostate CancerCastration-resistant Prostate Cancer
Shanghai Changzheng Hospital3 enrolled1 locationNCT06895811
Recruiting
Phase 2
Management of Oligoprogressive Castration Resistant Prostate Cancer (PCS X)
Metastatic Prostate CancerCastration-resistant Prostate Cancer
Sir Mortimer B. Davis - Jewish General Hospital66 enrolled10 locationsNCT04070209
Recruiting
Phase 3
Metastasis-directed Therapy in Oligoprogressive Castration-refractory Prostate Cancer
OligoprogressiveCastration-resistant Prostate Cancer
Universitaire Ziekenhuizen KU Leuven246 enrolled1 locationNCT06585007
Recruiting
Phase 1
Targeted Radionuclide Therapy in Metastatic Prostate Cancer Using a New PSMA Ligand Radiolabelled With Terbium-161 (161Tb-SibuDAB) - Dose Identification/Escalation Phase Ia/b Study
Castration-resistant Prostate Cancer
University Hospital, Basel, Switzerland25 enrolled1 locationNCT06343038
Recruiting
Phase 2
Disitamab Vedotin in the Treatment With HER2- Expression, Subjects With Locally Advanced or Metastatic Castration-resistant Prostate Cancer
Castration-resistant Prostate Cancer
RemeGen Co., Ltd.40 enrolled3 locationsNCT06227156
Recruiting
Early Phase 1
Clinical Study of Safety and Efficacy of Enhanced PSMA CAR- T in Refractory CRPC
Metastatic Castration-resistant Prostate CancerCastration-resistant Prostate Cancer
Shanghai Changzheng Hospital18 enrolled1 locationNCT06228404
Recruiting
Response Evaluation of Cancer Therapeutics in Metastatic Castration-Resistant Prostate Cancer to the Bone
Castration-resistant Prostate Cancer
European Institute of Oncology40 enrolled1 locationNCT06321679